Anaphylaxis is a severe, life-threatening hypersensitivity reaction that can occur rapidly after exposure to an allergen. Sugammadex is a novel neuromuscular blockade reversal agent used to counteract the effects of amino steroid muscle relaxants such as rocuronium and vecuronium. Although generally considered safe, there have been rare reports of anaphylaxis following sugammadex administration. This case report describes an incident of anaphylaxis triggered by sugammadex, highlighting the clinical presentation, management, and potential implications for anesthesia practice.
No takes yet. Share an insight, caveat, or question.
Osama Elsayed (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: